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Abstract
Background: Environmental factors during perinatal development may influence developmental plasticity and
disease susceptibility via alterations to the epigenome. Developmental exposure to the endocrine active
compound, bisphenol A (BPA), has previously been associated with altered methylation at candidate gene loci.
Here, we undertake the first genome-wide characterization of DNA methylation profiles in the liver of murine
offspring exposed perinatally to multiple doses of BPA through the maternal diet.
Results: Using a tiered focusing approach, our strategy proceeds from unbiased broad DNA methylation analysis using
methylation-based next generation sequencing technology to in-depth quantitative site-specific CpG methylation
determination using the Sequenom EpiTYPER MassARRAY platform to profile liver DNA methylation patterns in
offspring maternally exposed to BPA during gestation and lactation to doses ranging from 0 BPA/kg (Ctr), 50 μg
BPA/kg (UG), or 50 mg BPA/kg (MG) diet (N = 4 per group). Genome-wide analyses indicate non-monotonic effects
of DNA methylation patterns following perinatal exposure to BPA, corroborating previous studies using multiple doses
of BPA with non-monotonic outcomes. We observed enrichment of regions of altered methylation (RAMs) within CpG
island (CGI) shores, but little evidence of RAM enrichment in CGIs. An analysis of promoter regions identified several
hundred novel BPA-associated methylation events, and methylation alterations in the Myh7b and Slc22a12 gene
promoters were validated. Using the Comparative Toxicogenomics Database, a number of candidate genes that have
previously been associated with BPA-related gene expression changes were identified, and gene set enrichment
testing identified epigenetically dysregulated pathways involved in metabolism and stimulus response.
Conclusions: In this study, non-monotonic dose dependent alterations in DNA methylation among BPA-exposed mouse
liver samples and their relevant pathways were identified and validated. The comprehensive methylome map presented
here provides candidate loci underlying the role of early BPA exposure and later in life health and disease status.
Keywords: Bisphenol A, DNA methylation, Environmental epigenomics, MethylPlex
Background
The early developmental environment is an influential
predictor of subsequent phenotypes and disease risk
later in life. A growing body of work supports the
“developmental origins of health and disease” (DOHaD)
hypothesis, which posits that chemical and/or nutritional
influences during early life result in long-lasting effects
and point to epigenetic inheritance as a prime mechanism
[1,2]. Epigenetic modifications, such as DNA methylation
and chromatin markings, are established early in develop-
ment and can shape susceptibility to disease, resulting in
diverse phenotypes among genetically identical individuals
[3]. Until recently, however, most attempts to elucidate
the effects on the epigenome following environmental and
nutritional exposures were either candidate gene driven or
based on epigenetic techniques with limited genome
coverage/sensitivity. Using bisphenol A (BPA) as a repre-
sentative early environmental exposure alongside an
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established dose-dependent mouse model of perinatal
exposures [4-7], we have developed a comprehensive strat-
egy for evaluating environmental effects on the developing
epigenome (Figure 1).
BPA is a high-production volume monomer used in
the manufacture of polycarbonate plastic and epoxy
resins. It is present in products that are routinely used,
including food and beverage containers, baby bottles,
dental composites, and thermal receipt paper [8]. Several
studies have reported detectable levels of total urinary
BPA in a large proportion of populations around the
world [9-11]. An evaluation of circulating blood BPA
levels in pregnant women in southeast Michigan
indicated exposure levels between 0.5 μg/L and 22.3 μg/
L (mean 5.9 μg/L) [12], and our recent study of human
fetal liver samples indicated that there is considerable
exposure to BPA during pregnancy and that BPA in fe-
tuses was in a unconjugated form not readily eliminated
from the body [13]. These findings indicate that in utero
development and infancy may be particularly vulnerable
time periods for exposure to BPA.
Toxicology studies indicate BPA exposure, both at
high levels and levels well below the established U.S.
Environmental Protection Agency (EPA) reference dose
of 50 μg/kg body weight/day, results in a variety of
physiological changes implicated in breast and prostate
Image analysis
Base calling
Alignment
Methylation 
read counting
Analysis
Validation
Seq files
BWA
BED files
EdgeR in R
Candidate 
genes
a/a
X
Avy/a
Maternal BPA exposure
Control, 50 μg and mg BPA/kg diet
Genomic DNA from day 22 a/a offspring (N=12, 4 per group)
Enrich for CpG-rich regions
Perform High-throughput Sequencing
Using Illumina GAIIx 
Single-end, 80 bp reads
BP
A 
ex
po
su
re
D
N
A 
ex
tra
ct
io
n
&
m
e
th
yla
tio
n 
e
n
ric
hm
en
t
N
G
S
se
qu
en
cin
g
Bi
oi
nf
o
rm
a
tic
s 
a
n
a
lys
is
&
da
ta
 m
in
in
g
Ca
nd
id
at
es
&
va
lid
at
io
n
0      100      200      300       400      500 . . . . .
100 bp
50 bp
Scan the entire genome using
Moving window of 100 bp  
Moving shift size = 50 bp 
EdgeR 
analysis
Test for differences in each group
Control           UG             MG 
Figure 1 Experimental and bioinformatics pipeline. Next generation sequencing was performed after methylation-sensitive enzyme-based
enrichment using the Illumina Genome Analyzer IIx (GAIIx) platform with single-end read length of 80 bp on 12 genomic liver DNA samples
obtained from isogenic day 22 a/a mice, exposed to BPA through maternal dietary intake (control, 50 ug/kg diet, or 50 mg/kg diet; n = 4 per
group). To regions of altered methylation (RAMs) associated with BPA exposure group, the number of aligned sequencing reads per 100 bp
window with 50 bp moving shifts was obtained for each sample. edgeR analysis was performed after applying filters to remove the regions
with low reads. Top candidates were identified, and candidate RAMs were validated using EpiTYPER.
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cancer, reproductive dysregulation, and behavioral ab-
normalities [14,15]. Epidemiology studies have described
associations between increased BPA levels with cardio-
vascular disease risk, decreased semen quality, altered
childhood behavior, and recurrent miscarriages [16-19]. BPA
can mimic or antagonize endogenous hormones by binding
weakly to steroid receptors including estrogen receptors (ER
α and β) and thyroid hormone receptor [20-22]. BPA also
binds strongly to the trans-membrane ER, G protein-
coupled receptor 30 (GPR30), as well as the orphan nuclear
receptor estrogen related receptor gamma (ERRγ) [23,24],
and can also activate transcription factors, including peroxi-
some x receptor (PXR) and aryl hydrocarbon receptor
(AhR), which can dimerize with steroid receptors [25,26].
BPA is associated with epigenetic alterations following
developmental exposures [4,5,27-30]. In a rat model,
Ho and colleagues observed multiple changes in gene-
specific DNA methylation patterns in the adult male
prostate, including hypomethylation of the phospho-
diesterase type 4 variant 4 (Pde4d4) [27]. Hypomethyla-
tion of the nucleosome binding protein-1 (Nsbp1) gene
promoters and hypermethylation of the hippocalcin-like
1 (Hpcal1) gene promoter was also reported in rats fol-
lowing neonatal exposure to low concentrations of BPA
(10 μg/kg of body weight BPA) [30]. Altered methylation
and subsequent aberrant gene expression was associated
with a marked increase in prostate cancer risk. Using the
viable yellow agouti (Avy) mouse model, we have shown
that maternal dietary exposure to moderate levels of
BPA (50 mg BPA/kg diet) resulted in decreased DNA
methylation at the Avy, and CabpIAP metastable epialleles
[4,5], while exposure to lower doses (50 ng and 50 μg BPA/
kg diet) led to hypermethylating effects at these candidate
loci [5]. Finally, using restriction-enzyme based methylation
technology, Yaoi and colleagues reported both hyper- and
hypomethylation at a methylation-sensitive NotI loci in
murine offspring forebrain following gestational exposure
to 20 μg/kg body weight of BPA [28]. Recently, the differen-
tial methylation in imprinting control regions was reported
in maternally BPA-exposed mouse embryos and placentas
using pyrosequencing technology. This change in methyla-
tion also resulted in abnormal expression in placenta and
abnormal placental development [31].
Capitalizing on advances in whole-genome epigenomic
and high-throughput quantitative DNA methylation tech-
nologies, we developed a comprehensive approach to
identify the constellation of genomic loci with altered
epigenetic status following dose-dependent perinatal
BPA exposure. Using a tiered focusing approach, our
strategy proceeded from unbiased broad DNA methyla-
tion analysis using methylation-based next generation se-
quencing technology to in-depth quantitative site-specific
CpG methylation determination using the Sequenom Epi-
TYPER MassARRAY platform. We compared the regions
of altered methylation (RAMs) following BPA exposure
using bioinformatics and biostatistics methods, and the
cellular pathways in which the genes with nearby RAMs
function.
Results
Analysis pipeline and quality control for identifying
differential methylation
We used the MethylPlex-Next Generation Sequencing
(M-NGS) platform to evaluate genome-wide alterations
in DNA methylation following perinatal BPA exposure
in mice, which requires minimal DNA input (~ 50 nano-
grams) and enriches methylated DNA using a cocktail
of methylation-dependent restriction enzymes prior to
deep sequencing (Figure 1). Following alignment to the
reference mouse genome (version mm9), we confirmed
that MethylPlex library reads were enriched in genomic
regions containing higher numbers of genes and CpG
islands (CGIs) (Additional file 1: Figure S1). For initial
standardization of the data analysis pipeline, we em-
ployed a sex-based analysis comparing methylation pro-
files on chromosomes X and Y between female and male
offspring (Additional file 1: Figure S2). The difference in
mapped reads on chromosomes X and Y was clearly dis-
tinguishable between male and female samples with
minimal background noise observed on chromosome Y
from female samples. Upon examination of the chromo-
somal distribution of windows with significant differential
methylation applying the same criteria employed in the
exposure comparison strategy outlined in the Methods,
263 and 325 windows (total = 696) were located on
chromosome X and Y, respectively, compared with only
108 windows on autosomes (Additional file 1: Figure S3).
Despite the presence of a limited number of background
reads on chromosome Y in female samples, no regions on
this chromosome were identified to harbor hypermethyla-
tion in female samples. This analysis provides us an esti-
mate of the maximum false discovery rate (FDR) of 15.5%
(108/696 * 100%) for our analysis presented below; how-
ever, the actual FDR may be much lower, if true autosomal
differences in methylation exist between sexes.
BPA Exposure Dependent Regions of Altered Methylation
(RAMs)
When genome-wide DNA methylation patterns were
compared across BPA exposure categories (control vs.
MG, control vs. UG, and UG vs. MG), a small percent-
age (0.2 to 0.3%) of windows (106,765, 166,437, and
173,823 windows, respectively, in over 53 million win-
dows of 100 bp with 50 bp moving-shifts) were identified
as preliminary regions of altered methylation (RAMs)
(p-value < 0.05; Additional file 1: Figure S4A) prior to
applying additional filtering steps described in Methods.
Across the three BPA exposure comparisons, a majority of
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RAMs (82%, which is 310,024 out of 378,371 in 100 bp
windows) were distinct from one another (Additional
file 1: Figure S4B). RAMs were identified both within and
outside of CGIs, CGI shores (0-2 kb from CGI), and CGI
shelves (2-4 kb from CGI) (Additional file 1: Figure S4C).
To minimize the influence of a single sample in pre-
dicting RAMs, we further analyzed data with filtered
RAMs that 1) exhibited methylation change in at least
two samples per exposure category and 2) displayed dif-
ferential methylation either in at least one out of two
flanking windows (shift window size is 50 bp) or two
100 bp windows within a 500 bp stretch. These filtering
steps were used for the male versus female comparison
and thus are expected to result in an FDR no greater
than 15.5%. We then conducted a refined downstream
analysis, similar to the unfiltered analysis described above.
Following filtering, within each exposure comparison we
observed a greater number of hypermethylated RAMs
compared to hypomethylated RAMs (Figure 2A and C).
The largest number of RAMs was observed when UG
exposed offspring were compared to MG exposed offspring
(N = 11,647 genome-wide, and N = 428 promoter-region
only, Figure 2A and C). The control versus UG exposure
category resulted in the smallest number of RAMs (N =
2,028 genome-wide, and N = 93 promoter-region only),
while the control versus MG exposure category resulted in
5772 genome-wide and 227 promoter region RAMs
(Figure 2A and C). Similarly to the unfiltered analysis
above, across the three BPA exposure categories, RAMs
were largely distinct from one another (Figure 2B and D).
Using the filtered dataset, we also examined the distri-
bution of RAMs among CGIs, CGI shores (0-2 kb from
CGI), and CGI shelves (2-4 kb from CGI), and compared
these to the proportion of the M-NGS library and mouse
\genome (mm9) covered by CGIs, CGI shores, and CGI
shelves. The distribution of CGIs, CGI shores, and shelves
in the mouse genome (mm9) is shown in Additional file 1:
Figure S5, where less than half of the genome was shown
to be associated with CGIs, CGI shores, or shelves. In
the M-NGS libraries enriched for CGs, over 85% of the
reads were associated with CGIs, CGI shores, or shelves
(43% in CGI shores, 27% in CGIs, and 16% in CGI
shelves). Less than 15% of the reads were located outside
of CGIs and their surrounding area (14%) (Figure 2E).
Approximately half of the total differential regions
were located within CGI shores in the Ctr vs. MG
(51%) and the UG vs. MG (50%) comparisons, followed
by CGI shelves, which accounted for over 20% of the
total differential regions (Figure 2E). In the Ctr vs. UG
comparison, however, a smaller proportion of the differential
regions were located within CGI shores (38%) and shelves
(15%) (Figure 2E). The relative distribution of CGIs, shores,
and shelves of the RAMs in comparison with the M-NGS
library identified a slight enrichment of RAMs in CGI
shores (18.6% increase in Ctr vs. MG and 16.3% increase
in UG vs. MG) and CGI shelves (43.7% increase in Ctr vs.
MG and 37.5% increase in UG vs. MG), and depletion of
RAMs (63% decrease in Ctr vs. MG and UG vs. MG, and
78% decrease in Ctr vs. UG) in CGIs. In the Ctr vs. UG
comparison, the relative distribution was decreased in
CGI shores by 11.6%, in contrast with Ctr vs. MG and
UG vs. MG comparisons with an increase in relative
distribution of CGI shores. These results identified the
CGI shores and shelves to be the more susceptible and
CGIs to be more resistant to methylation changes
upon environmental exposure. Additional pie charts in
Additional file 1: Figure S5 display the proportion of
hyper- and hypo-methylated regions with respect to
CGIs, CGI shores, and shelves.
In addition, we examined the distribution of epigenetic
changes within various genomic locations including
exons, 5′ and 3′ untranslated regions (UTRs), and
within 1 and 5 kb of transcription start sites (TSSs) upon
various BPA exposures using RSeQC package [32]. In
Ctr vs. MG and UG vs. MG analyses, the genomic distri-
bution of differentially methylated regions showed more
than 3-fold enrichment of coding sequence (CDS) exons
(3.3 fold increase in Ctr vs. MG and 3.6-fold increase in
UG vs. MG) compared to background levels in the
mouse genome (Figure 2F). In addition, the enrichment
of 5′ (1.4-fold increase in Ctr vs. MG and 1.8-fold in-
crease in UG vs. MG) and 3′UTRs (2.1-fold increase in
Ctr vs. MG and 2-fold increase in UG vs. MG) and the
depletion of the upstream TSSs (1.4-fold decrease in
both Ctr vs. MG and UG vs. MG for 1 kb and 1.3-fold
decrease in Ctr vs. MG for 5 kb) was observed. In the
Ctr vs. UG analysis, however, the genomic distribution
difference between the RAMs and the mouse genome
background was not observed, except for a 2-fold increase
in CDS exons. Despite the small overlap of RAMs
between Ctr vs. MG and UG vs. MG comparisons,
the genomic and CGI distributions of the differential
regions were highly similar, and unlike the Ctr vs. UG
comparison, the results deviated from the genomic
background.
Promoter regions associated with BPA-dependent regions
of altered methylation
Differential methylation in promoter regions may play
a substantial role in gene transcriptional regulation.
The identified RAMs in promoter regions (N = 1,065,
p-value < 0.05) that occur within ±1.5 kb from TSSs
are visualized in Figure 3. Fifty-three percent of
RAMs gained methylation at promoters (N = 569),
and forty-seven percent lost methylation (N = 496)
upon BPA exposure. Promoter RAMs can be further
classified into types that respond to UG exposure,
respond to MG exposure, or respond to both exposures.
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For RAMs with a gain of methylation, only a small propor-
tion of the TSSs were associated with the UG exposure only
(N = 60). Thus, gains of methylation upon exposure were
either observed in both the UG and MG exposure groups
(N = 277) or in only the MG exposure group (N = 232). For
RAMs with a loss of methylation, a large proportion of the
TSSs were affected by the UG exposure only (N = 363),
while only a small number of TSSs showed differential
methylation upon both UG and MG exposure groups (N =
44) or only in the MG exposure group (N = 89).
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Figure 2 Characterization of genome-wide methylation in BPA-exposed offspring. The genomic distributions of regions of altered
methylation (RAMs), delineated as genome-wide or within promoter regions, from the edgeR analysis with p-value < 0.05 are displayed. (A) The
bar graph identifies the number of RAMs in genome-wide scale. (B) The Venn diagram displays the overlap of RAMs among control (Ctr), 50 μg
(UG) and 50 mg (MG) diet groups. (C) The bar graph and (D) Venn diagram of RAMs within promoter regions is displayed. (E) For each exposure
comparison and for the full M-NGS library, pie charts display the proportion of RAMs in number of windows at CpG islands (CGIs), CpG shores,
CpG shelves, and the remainder of the genome. In the Ctr vs. MG and in the UG vs. MG comparisons, approximately half of the RAMs occur
in CpG shores (0-2 kb from CGIs). (F) The genomic distributions of RAMs (p-value < 0.05) at 5′UTRs, TSSs, CDSs, and 3′UTRs are delineated in
bar graphs. The percentage of RAMs at CDS exons in the Ctr vs. UG comparison is decreased by more than half compared to other group
comparisons. At the TSSs, the percentage of RAMs is comparable among the three group comparisons.
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Enriched gene ontology terms and pathways among BPA
exposure dependent differentially methylated genes
We examined the enrichment of Gene Ontology (GO)
terms and pathways present in our candidate regions
within 1.5 kb of a TSS (N = 19,720; Additional file 2:
Table S3) using the Gene Set Enricher application from
the Comprehensive Toxicogenomics Database (CTD)
site, and the results were visualized using the REViGO
web application (Figure 4). GO biological processes
enriched for BPA-exposure RAMs in Ctr vs. MG com-
parison (n = 198 genes, FDR < 0.05) included metabolism
and stimulus response (Figure 4A; Additional file 2:
Table S4). Only 4 significant GO molecular functions
were observed, and they were involved in general bind-
ing activities (binding, protein and ion binding, catalytic
activity, FDR < 0.05). The significant pathways altered
include transmembrane transport of small molecules
(REACT:15518) and metabolism (REACT:111217). In
the Ctr vs. UG comparison, 76 genes were assessed, and
two GO biological process terms include metabolic
process and cellular process (Figure 4B). In addition,
cancer related pathways were enriched (KEGG:05200)
(Additional file 2: Table S4). For the UG vs MG com-
parison, a total of 371 genes were assessed, and we ob-
served strong enrichment of GO terms involved in
metabolic processes and stimulus as well as signaling
processes (Figure 4C). The significant pathways include
glutamatergic synapse (KEGG:04724) and regulation of
autophagy (KEGG:04140) (Additional file 2: Table S4).
Enriched GO terms and pathway analysis was also per-
formed on 156 known BPA-interacting genes (curated
from the CTD), that are known to be expressed in the
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mouse liver from Mouse Genome Informatics Gene Ex-
pression Database and compared with the results from
our methylation data (Additional file 2: Table S5). This
analysis identified 67 pathways and 912 GO terms that
are significantly enriched among BPA-interacting genes,
representing genes whose altered DNA methylation may
be associated with concomitant gene expression changes
in the liver. Some of the top pathways include pathways
in cancer (KEGG:05200, FDR < 2.77e-28), metabolism
(REACT:111217, FDR < 2e-21), and adipocytokine signa-
ling pathway (KEGG:04920, FDR < 1.56e-10). By identi-
fying enriched pathways using two lists, including one
focusing on epigenetically altered genes and another on
transcriptionally regulated genes, the similarities as well
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Figure 4 Enriched biological processes among genes harboring differential methylation. The genes harboring differential methylation
within their promoters (FDR adjusted p-value < 0.05) were subjected to GO term enrichment analysis. (A) A total of 198 genes from Ctr vs. MG
comparison, (B) 76 genes from Ctr vs. UG comparison, and (C) 371 genes from UG vs. MG comparison are used for the analysis, and enriched
pathways are involved in basic biological processes, including basic cellular, metabolic, and immune and stimulus responses, as well as some
binding activities. The enriched biological processes are graphed using REViGO software. The colors of the circles represent the various levels
of statistical significance, where the darker shade represents more significance in p-values than the lighter one. The various sizes of the circles
represent the number of genes in given GO terms. A complete list of GO terms including cellular components and molecular functions is
available in Additional file 2: Table S4.
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as the differences between the affected pathways via two
different mechanisms can be compared.
In addition to our promoter based enrichment analysis
above, whose differential sites were restricted to within
1.5 kb of TSSs, we also performed pathway enrichment
analysis with all RAMs using ChIP-Enrich (http://chip-
enrich.med.umich.edu). The ChIP-Enrich application as-
signs peaks to genes based on a chosen method (we used
nearest TSS) and tests peaks from ChIP-seq experiments
for enrichment of biological pathways, GO terms, and
other types of gene sets using an empirical method to
adjust for the relationship between probability of a peak
and the genomic length associated with a gene. Associat-
ing genomic sites or peaks to nearest TSSs has been
widely applied in the biological functional analysis of
ChIP-Seq data [33]. In the Ctr vs. MG and in the UG vs.
MG comparisons, similar pathway enrichments were
obtained as seen in our promoter region based testing,
mainly metabolism and its related processes (FDR <
0.01), as well as GO terms related to development and
morphogenesis (FDR < 0.01) (Additional file 2: Table S6).
In the Ctr vs. UG enrichment results, only 7 GO terms
were significant with FDR < 0.1, while there are 109
terms enriched in Ctr vs. MG, and 119 terms enriched
in UG vs. MG comparisons (FDR < 0.1). Three of the
top 7 enriched GO terms were lipoprotein particle re-
ceptor activity (FDR < 0.04), low-density lipoprotein re-
ceptor activity (FDR < 0.07), and apolipoprotein binding
(FDR < 0.09).
Validation of regions of altered methylation using
sequenom EpiTYPER
RAMs from 5 genomic regions were quantitatively vali-
dated using the Sequenom EpiTYPER platform. We vali-
dated two RAMs located in the gene promoters of
myosin, heavy chain 7B, cardiac muscle, beta (Myh7b)
(p-values < 0.006, 300 bp windows) and renal-specific
transporter (Slc22a12) (p-values < 0.009, 300 bp win-
dows) (Additional file 2: Table S7). Both of these genes
were associated with metabolic process in our ChIP-
Enrich testing (FDR < 1.6E-4 and 2.9E-5 in UG vs. MG
and Ctr vs. MG comparisons). Several enriched concepts
involved in binding processes such as ribonucleotide, nu-
cleotide, actin, and cytoskeletal protein bindings (FDR <
0.05) in our ChIP-Enrich analysis were associated with
Myh7b, and those involved in transport activities and
nitrogen metabolic process (FDR < 0.05) were associated
with Slc22a12. The methylation gain in the promoter
region of Myh7b in both the UG and MG exposures
(Figure 3) was validated, showing a median methylation
of 30.1% (22.8 for Quartile 1, Q1 and 35.4 for Quartile 3,
Q3) in Ctr compared to 36.8% (32.5 for Q1 and 38.3 for
Q3) in UG and 38.1% (34.3 for Q1 and 48.6 for Q3) in
MG (Figure 5A). The gene expression change in Myh7b
was monitored using real-time qPCR, revealing no
change in expression in PND22 mouse livers. The hypo-
methylation in the Slc22a12 promoter region in the UG
exposure group (Figure 3) was confirmed with a median
methylation level across four CpG sites observed at 90%
(89.5 for Q1 and 92 for Q3) in Ctr, 84% (82.1 for Q1 and
88.8 for Q3) in UG, and 89% (85.5 for Q1 and 92.9 for
Q3) in MG. The decrease in methylation at CpG site 2 in
UG exposure group was statistically significant compared
to Ctr (p-value < 0.004) and MG (p-value < 0.01) groups
(Figure 5B). The gene expression change in Slc22a12 was
assayed via qPCR, revealing that this gene is not expressed
in PND22 mouse liver tissue.
Additionally, we measured methylation in three RAMs
in intergenic regions from chromosome 1, 4, and 18 to
confirm differential methylation associated with BPA ex-
posure. Hypomethylation was validated in the region
from chromosome 18 (p-value < 0.036) (Figure 5C), with
a median methylation level of 82.5% (77.1 for Q1 and 86
for Q3) in the Ctr group compared to 72.5% (68 for Q1
and 77 for Q3) in UG and MG BPA group. The inter-
genic region from chromosome 4 was hypermethylated
as indicated by the M-NGS (p-value < 0.035) with a me-
dian methylation of 86% (79 for Q1 and 98 for Q3) in
the Ctr group, compared to 97.5% (92 for Q1 and 100
for Q3) in the UG BPA group, and 95.0% (91 for Q1
and 97.5 for Q3) in the MG group (Figure 5D). The
remaining region on chromosome 1 that showed a
M-NGS identified loss of methylation with BPA expos-
ure was not differentially methylated following bisulfite
sequencing validation (p-value > 0.35), with a median
methylation of 85.7% (77.7 for Q1 and 90.8 for Q3) in
Ctr, 82.7% (81.7 for Q1 and 85.3 for Q3) in UG, and 87%
(84.7 for Q1 and 91 for Q3) in MG groups.
Discussion
We have previously shown that BPA exposure at 50 mg
BPA/kg diet during development plays a role in epigen-
etic programming at candidate metastable loci Avy and
CabpIAP [4]. In a follow-up study using multiple doses of
dietary BPA exposures, we observed dose-dependent ef-
fects on DNA methylation at Avy and CabpIAP with the
lower doses (50 μg and 50 ng BPA/kg diet) leading to
the opposite, hypermethylating effect [5]. We have now
employed a next-generation sequencing approach and
identified non-monotonic effects on the DNA methy-
lome following human physiologically relevant perinatal
BPA exposures. The identification of low dose and non-
monotonic effects of endocrine disrupting chemicals,
such as BPA, is a topic of growing interest in toxicology
and endocrinology [15].
Genome-wide platforms allow for identification of the
constellation of genomic loci with altered epigenetic sta-
tus following exposure or in relation to disease status.
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For example, Irizarry et al. used a microarray approach
and demonstrated that approximately 70% of methyla-
tion changes in colon cancer samples occurred in
“shores” defined as regions up to 2 kb away from CpG
islands [34]. Newer approaches to query the methylome
now involve next-generation sequencing, and the tech-
nology in this field is rapidly advancing, including whole
genome and reduced representation bisulfite sequencing,
which quantitatively measure methylation changes at
single-based resolution, yet remain costly in addition to
the need for complex bioinformatics pipelines. An
alternative to bisulfite conversion approaches include
affinity enrichment techniques (e.g. MeDIP-seq and
MBD-seq) that involve the enrichment of methylated re-
gions via methylation-targeted antibody or protein.
These methods, however, are sensitive to antibody lot
that may lead to inconsistent enrichment between exper-
iments. In this project, we employed the MethylPlex-
Next Generation Sequencing (M-NGS) platform, which
uses enzymatic enrichment to identify regions of altered
methylation and requires only 50 ng of starting genomic
material. Because the exact composition of the enzymes
used for the methylation enrichment is proprietary infor-
mation (Patent Number US 2007/0031858 A1), we
assessed CG enrichment prior to downstream analysis
and confirmed an average of 2.3 fold CG enrichment
across our 12 study samples compared to mouse refer-
ence genomes using this technology. In addition, we
have previously assessed and published on the perform-
ance of the MethylPlex platform on CG enrichment in
prostate cancer cell lines and tissues [35].
Our genome-wide analysis of liver DNA from mouse
offspring exposed to BPA indicates that DNA methyla-
tion patterns exhibit non-monotonic effects following
perinatal exposure to BPA, corroborating previous stud-
ies using multiple doses of BPA with non-monotonic
outcomes [36,37]. We observed an enrichment of RAMs
in CGI shores, accounting for nearly half of the identi-
fied RAMs in MG BPA group compared to either con-
trol or UG BPA groups. This suggests that CGI shores
and regions outside of often-profiled CpG islands may
be more susceptible to epigenetic changes following
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Figure 5 Candidate region validation using Sequenom EpiTYPER. RAMs from candidate regions including (A) Myh7b and (B) Slc22a12
promoters and (C, D) two intergenic regions from 29 mouse liver samples including the 12 original samples sequenced for M-NGS were
quantitatively validated via Sequenom EpiTYPER and shown as box plots.
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perinatal exposures. For example, RAMs identified in
the higher BPA exposure group (MG) were more likely
to be located within CGI shores, and CGIs were more
resistant to epigenetic change. In the lower BPA expos-
ure group (UG), however, an enrichment of the RAMs
among CGI shores was not observed; instead regions
with low CG density were highly enriched as RAMs. In
addition, the overall distribution of the RAMs within
CDS, UTRs, and TSSs was also distinct between MG
and UG exposed samples.
In order to identify gene promoters with altered DNA
methylation upon exposure, we scanned ±1,500 bps
flanking the TSSs of 30,637 transcripts in the mouse gen-
ome (mm9). This analysis indicated distinct exposure-
dependent methylation patterns around TSSs (span of
3,000 bp) and identified several hundred novel BPA-
induced promoter methylation events. Several of the iden-
tified promoter methylation events occurred in genes
previously associated with transcriptional change follow-
ing BPA exposure, including Hmgn5, Hpcal1, Hoxa10,
Brca1, Pde4d [27], and Esr1 and Esr2 [29]. In addition, de-
creased promoter methylation and increased expression
were reported in high mobility group nucleosome binding
domain 5 (Hmgn5) from the prostate of male adult rat
neonatally exposed to 10 μg BPA/kg diet [30], and in
Homeobox protein Hox-A10 (Hoxa10) from the re-
productive tract of CD-1 mice neonatally exposed to 5 mg
BPA/kg diet [38]. Increased promoter methylation and
decreased expression in Hippocalcin-like protein 1
(Hpcal1) in new born male rats exposed to 10 μg BPA/kg
diet [30] and breast cancer type 1 susceptibility protein
(BRCA1) in human mammary epithelial cells exposed to
BPA for 1 week at the early passage [39] have also been re-
ported. Using the Comparative Toxicogenomics Database
(CTD), we identified 25 genes with previously reported
changes in gene expression upon BPA exposure that also
harbored aberrant DNA methylation near promoters in
our BPA-exposed mouse liver samples (Figure 3).
To perform technical validation as well as to identify
true differential methylation target genes upon BPA ex-
posure, the original 12 samples along with 17 additional
samples were included in the validation set. Two of the
validation loci were located within gene promoter re-
gions, and thus an alteration in methylation upon BPA
exposure may result in concomitant gene expression
changes. One of our candidate genes that gained methy-
lation upon BPA exposure in our M-NGS data was
Myh7b. Quantitative and CpG site specific validation
using the Sequenom EpiTYPER platform confirmed the
increase in DNA methylation within the promoter re-
gion of Myh7b in a monotonic dose-dependent manner
(e.g. the higher the BPA exposure, the higher the methy-
lation level). The MYH7B protein is known to interact
with ESR2 [40], and one of the MYH7B estrogen-
response elements (ERE) (www.genomatix.de) is located
within an identified RAM. Despite the validated quanti-
tative change in methylation in the Myh7b promoter,
no exposure dependent alteration in expression was
observed in PND22 mouse liver samples. During devel-
opment, genes exhibit unique time windows of expres-
sion, and it’s possible a change in expression may have
been missed or could occur at a future time point. Alter-
natively, the observed altered methylation upon BPA ex-
posure may merely be an effect on the epigenome that
will not manifest itself in a change in expression, protein
level, or protein activity. Slc22a12 is a candidate RAM
displaying decreased level of methylation upon BPA ex-
posure. In humans, the presence of single nucleotide
polymorphisms (SNPs) in the SLC22A12 gene was found
to be associated with obesity and metabolic syndrome in
Caucasians with hypertension [41]. As in the M-NGS
data, a significant decrease in DNA methylation was ob-
served in samples in the UG exposure group, but not in
the MG exposure group, adding to the weight of evi-
dence supporting non-monotonic epigenetic responses
following BPA exposure.
Our pathway analysis indicated strong enrichment of
genes involved in metabolism and stimulus response
upon BPA exposure. This observation, in combination
with previously reported data supporting a role for BPA
in immune [42-45] and metabolic response [6,46-49],
indicates the importance of changes in epigenetic pathways
following perinatal exposures as a mechanism linking
developmental exposures to disease risk in adulthood.
For example, the activity of the adiponectin gene, which
codes for a hormone controlling insulin sensitivity, was
previously shown to be suppressed by BPA [49], implicat-
ing BPA in the development of type 2 diabetes. Stimulus
response upon BPA exposure was previously identified in
a prenatally BPA-exposed mouse with increased regula-
tion of T helper 1 and 2 immune responses [43]. Estrogen
is a known regulator of the immune response through
various activities including the secretion of interferon-Ɣ
and cytokine [50,51]. Several immune response experiments
of environmental exposures including BPA have been
previously conducted; in a mouse study, female offspring
of mothers exposed to > 50 μg BPA/kg had elevated lung
inflammation, compared with offspring of control dams
[42]. Further, prenatal exposure to 10 μg BPA/mL in
drinking water enhanced allergic sensitization and bronchial
inflammation and responsiveness in a susceptible animal
model of asthma [45].
To understand the full extent of BPA and associated
perinatal exposures on the epigenome as a whole, it will
be important to incorporate genome-wide analysis other
epigenetic mechanisms such as histone modifications
and non-coding RNAs, as well as full transcriptome
analyses, such as RNA-seq. Indeed, we have recently
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identified DNA methylation and histone modifications
to act in concert with one another at the Avy metastable
epiallele [52]. Increasing the number of studies focusing
on multiple epigenetic mechanisms will strengthen the
understanding of environmentally induced alterations to
the epigenome.
Conclusions
It is increasingly recognized that environmental expos-
ure to chemical, nutritional, and behavioral factors alters
gene expression and affects health and disease by not
only mutating promoter and coding regions of genes,
but also by modifying the epigenome. The investigation
of early environmental effects can inform the fields of
toxicology and environmental epidemiology by elucidat-
ing the mechanisms underlying developmental exposure
and disease risk later in life. The identification of epige-
nomic loci dysregulated in a dose-dependent manner
will ultimately strengthen human health risk assessment
and shape diagnostic and therapeutic strategies for dis-
ease. The mouse is a tractable and popular model for
human diseases; however animal models for toxicology
studies may not be the best choice for modeling the
potential impact on the human genome if the repertoire of
epigenetically labile genes is markedly species dependent.
Additional toxicologically relevant animal models, including
rats and sheep should also be considered for this approach
along with parallel approaches in human tissues. Ultimately,
researchers must integrate the layers of epigenetic changes
with the windows of susceptibility to understand and gener-
ate the best prescriptions for human health and disease.
The comprehensive methylome map presented here will
further our understanding on the methylation targets of
BPA exposure. Since epigenetic profiles, unlike genetic mu-
tations, are potentially reversible, approaches for prevention
and treatment, such as nutritional supplementation and/or
pharmaceutical therapies, may have significant impact on
disease trajectory and, ultimately, human health.
Methods
Mouse liver tissue samples
Mice were obtained from a colony that has been main-
tained with sibling mating and forced heterozygosity for
the viable yellow agouti (Avy) and non-agouti (a) alleles
for over 220 generations, resulting in a genetically invari-
ant background [53]. To avoid effects associated with
parity, virgin wild-type a/a dams, 6 weeks of age, were
randomly assigned to one of three phytoestrogen free
AIN-93G diets (diet 95092 with 7% corn oil substituted
for 7% soybean oil; Harlan Teklad, Madison, WI): 1)
standard diet (n = 11 litters); 2) standard diet supple-
mented with 50 μg BPA/kg diet (n = 9 litters); or 3)
standard diet supplemented with 50 mg BPA/kg diet
(n = 13 litters). All diet ingredients were supplied by
Harlan Teklad except BPA, which was supplied by NTP
(National Toxicology Program, Durham NC). The MG
dosage is an order of magnitude lower than the dietary
administered maximum non-toxic threshold in rodents
(200 mg/kg body weight/day) [54], but, it is important to
note, as previously reported, that the BPA dosages cap-
ture human physiologically relevant exposure [5,55].
Wild-type a/a dams were provided with their respect-
ive diet two weeks prior to mating with 8-week-old
Avy/a males and housed in polycarbonate-free cages with
ad libitum access to diet and BPA-free water. The dams
remained on the assigned diets throughout pregnancy
and lactation, after which offspring were sacrificed at
post-natal day 22 (PND22). This mating scheme pro-
duces approximately 50% a/a genotype and 50% Avy/a
offspring. For this study, liver DNA from a subset of a/a
wild-type animals was analyzed for full methylome char-
acteristics: 1) standard diet (Ctr, n = 4 offspring; 2 male
and 2 female); 2) 50 μg BPA/kg diet (UG, n = 4 offspring;
2 male and 2 female); 3) 50 mg BPA/kg diet (MG, n = 4
offspring; 1 male and 3 female). To validate epigenome-
wide DNA methylation findings, liver DNA from add-
itional PND 22 a/a animals was evaluated including:
1) standard diet (n = 14 offspring; 9 male and 5 female);
2) 50 μg BPA/kg diet (n = 5 offspring; 3 male and 2 fe-
male); 3) 50 mg BPA/kg diet (n = 10 offspring; 4 male
and 6 female). From these mice, total genomic DNA was
isolated from liver tissue using buffer ATL, proteinase K,
and RNase A (Qiagen Inc., Valencia, CA), followed by
phenol-chloroform extraction and ethanol precipitation.
DNA quality and concentration was assessed using
a ND1000 spectrophotometer (NanoDrop Technology,
Wilmington, DL).
Animals used in this study were maintained in accord-
ance with the Guidelines for the Care and Use of Labora-
tory Animals (Institute of Laboratory Animal Resources,
1996) and were treated humanely and with regard for alle-
viation of suffering. The study protocol was approved by
the University of Michigan Committee on Use and Care
of Animals.
M-NGS library generation
MethylPlex library synthesis and GC-enrichment service
was obtained through a commercial service at Rubicon
Genomics Inc., Ann Arbor, MI (Patent Number US
2007/0031858 A1) [56]. The ability of MethylPlex com-
bined with next-generation-sequencing (M-NGS) to
identify regions of altered methylation was previously
evaluated using prostate cancer cell lines and tissues,
and the detail of the M-NGS methods is provided in
Kim et al. [35]. Briefly, fifty nanograms of genomic DNA
were digested with a proprietary cocktail of methylation-
sensitive restriction enzymes and then amplified by PCR
with universal primers to create a MethylPlex library
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that is enriched for methylated DNA. MethylPlex DNA
was then subjected to additional enzymatic treatment to
deplete all non-GC-rich DNA sequences, purified and
amplified in a second round of PCR. After purification,
amplification adaptors were removed by a restriction
enzyme digest, and the purified products were directly
incorporated into the Illumina genomic DNA sequencing
sample preparation kit procedure (Illumina Inc., San
Diego, CA) at the end repair step, skipping the nebuliza-
tion process. An adenine base was then added to the puri-
fied end repaired products using Klenow exo (3′ to 5′ exo
minus) enzyme. The reaction product was purified, ligated
to Illumina adaptors with DNA ligase and resolved on a
2% agarose gel. Gel pieces were excised at 400 base pair
positions, and the DNA was extracted using Qiagen gel
extraction kit (Qiagen Inc., Valencia, CA).
M-NGS sequencing and alignment
The purified MethylPlex library was analyzed by Bioanaly-
zer (Agilent Technologies, San Diego, CA) before subject-
ing it to flow cell generation, where 10 nM of library was
used to prepare flowcells with approximately 30,000 clus-
ters per lane, with the sequencing performed by the
University of Michigan DNA Sequencing Core. The raw
sequencing image data obtained by Illumina GAIIx using
80 cycles of single ends were analyzed by the Illumina
analysis pipeline. Around 30 million reads per sample
(ranging between 27 to 37 million reads) were obtained,
where approximately 70% of these were mapped uniquely
to the mouse mm9 reference genome using Burrows-
Wheeler Aligner (BWA) tool (Additional file 2: Table S1).
Tiered approach edgeR analysis
We adopted a tiered-based profiling pipeline to identify
regions of altered methylation (RAMs) by examining the
locus-specific genome-wide methylation patterns associ-
ated with BPA exposure levels (Figure 1). First, we
scanned the entire genome using a window size of
100 bp with a 50 bp moving shift, which accounts for
over 53 million windows for each sample. The genomic
regions containing at least 10 reads in 25% of the sam-
ples (~ 4 million windows) were then subjected to edgeR
analysis, which we used to test for differences in each
exposure group [57]. This step removed the regions with
low reads (no methylated CGs present in our sequencing
library). The edgeR analysis using R software was run
using the glmFit function, which uses a negative bino-
mial generated linear model, and identified the regions
with differential methylation in three different compari-
sons; the methylation levels from the control group
(n = 4) against the 50 μg BPA/kg diet group (Ctr vs. UG,
n = 4), control group against 50 mg BPA/kg diet group
(Ctr vs. MG, n = 4), and 50 μg BPA/kg diet group against
50 mg BPA/kg diet group (UG vs. MG). For downstream
analysis, identified RAMs were restricted to those that
are present in at least half of the samples per exposure
group with a differential methylation span of at least 2
adjacent windows (span of 150 bp) or 2 non-adjacent
windows (span of 200 bp) within a genomic distance of
500 bp. The above filtering step was performed to
minimize the sample-specific methylation variation af-
fecting the results. In addition, using the methylation
reads mapped to chromosome X and Y, the underlying
methylation difference among male and female samples
was distinguished and re-confirmed the sex of each
mouse sample (5 male vs. 7 female). Using the mm9
Refseq annotation available from the UCSC genome
browser, the gene promoters and microRNA loci within
RAMs were scanned using BEDtools and in-house perl
script. The complete list of RAMs and associated gene
promoters and microRNA loci is available in Additional
file 2: Table S3. The promoter methylation RAMs
(N = 1,065, p-value < 0.05) that occur within ±1.5 kb
from TSSs (mm9 Refseq) containing either low reads in
at least one exposure group or at least a 5-fold change
in methylation reads between any two exposure groups,
were visualized using a heatmap.
Gene set enrichment testing
The results from edgeR analysis after applying filters and
removing sample-specific methylation variation resulted
in 225 (Ctr vs. MG), 96 (Ctr vs. UG), and 421 (UG vs.
MG) unique genes (p-value < 0.05) harboring RAMs
within ±1.5 kb from TSSs. These represent the list of
genes displaying altered methylation at each BPA expos-
ure. The GO term and pathway enrichment analysis
was performed using Gene Set Enricher from Compara-
tive Toxicogenomics Database (CTD) using corrected
p-value threshold of 0.05 [58,59]. A total of 60, 9, and 56
GO terms (in Ctr vs. MG, Ctr vs. UG, and UG vs. MG
comparisons, respectively) were enriched, and the results
were visualized using Reduce and Visualize Gene Ontol-
ogy (REViGO) web application (revigo.irb.hr), which re-
moved redundant GO terms and linked highly similar
GO terms with the similarity cutoff value of 0.5 using
the Mus musculus database [60]. Enriched GO terms
and pathway analysis was also performed on the 156
known BPA-interacting genes (curated from the CTD)
that are expressed in the mouse liver, obtained from the
Mouse Genome Informatics Gene Expression Database
using a corrected p-value of 0.01. Genome-wide region
enrichment of GO terms was performed using ChIP-
Enrich application using all genomic-regions (p-value <
0.05) that passed the filter for eliminating sample-
specific methylation variation described above. Genome-
wide region enrichment of GO terms and pathways was
performed using ChIP-Enrich (http://sartorlab.ccmb.med.
umich.edu/chip-enrich) package available in R software
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with the nearest TSS locus definition and mouse assembly
(mm9) on all genomic-regions that passed the filter for
eliminating sample-specific methylation variation de-
scribed above.
Quantitative methylation validation
Top candidate regions were selected based on various
factors, including p-values, the number of samples with
RAMs, the number of reads, and the methylation status
of adjacent regions. Among the five candidate regions
selected for validation, two were located within ±1.5 kb
of TSSs. Genomic DNA from liver tissue from postnatal
day (PND) 22 a/a mouse samples (N = 29), including the
samples that were sequenced using M-NGS in this
study, were bisulfite treated using the EpiTect bisulfite
kit (Qiagen Inc., Valencia, CA) to allow for the conver-
sion of unmethylated cytosines to uracil (read as thy-
mine during PCR amplification), whereas the methylated
cytosines remain unconverted [7]. Bisulfite converted
DNA was then amplified using Bio-Rad (Model #C1000)
thermal cyclers (see Additional file 2: Table S7 for
primer information and PCR conditions). Amplified
products were subjected to the Sequenom EpiTYPER
platform (Sequenom, San Diego, CA), performed in the
University of Michigan DNA Sequencing Core. For each
primer set, the methylation percentage across CG sites
was averaged for each sample and boxplots were used to
visualize this data in Figure 5. For the primer set target-
ing chr18:80754900–80756100, we experienced a failed
assay on 4 samples and were unable to provide boxplots
with whiskers for the UG group. As the BPA exposure
groups were monotonic at this locus in the M-NGS dis-
covery stage, we pooled the UG and MG groups and
used this data in Figure 5C. The differences in mean
methylation levels of the samples (14 samples in Ctr, 5
in UG, and 10 in MG) in each paired group (Ctr vs. UG,
Ctr vs. MG, and UG vs. MG) were tested using two-
tailed t-test.
Quantitative real-time qPCR validation
Total RNA was isolated from 10–20 mg of frozen liver
from the same set of samples assayed for quantitative
methylation via the RNeasy Mini kit (Qiagen, Valencia,
CA) according to the manufacturer’s instructions includ-
ing the optional DNase digestion step. The purity and
quantity of RNA was assessed using the Nanodrop
2000 spectrophotometer (Thermo Scientific, Wilming-
ton, DE). To produce complementary DNA for each
sample, 1 μg of total RNA template was used with the
iScript cDNA synthesis Kit (Bio-Rad, Hercules, CA) fol-
lowing the manufacturer’s protocol. The qPCR primers
for Myh7b and Slc22a12 were designed using GenScript
Real-time PCR primer design bioinformatics tools
(www.genscript.com). The primer sequences for RT-qPCR
were as follows: Myh7b forward primer 5′-AGTTG-
GAGTTGTCCCAGGTC; Myh7b reverse primer 5′-TG
CGCCTCAGGTTAGTACAC; Slc22a12 forward primer
5′-CACGTGGGACCTGGTATGTA; Slc22a12 reverse
primer 5′-CCCAAACCTATCTGAGGCAT; Gapdh for-
ward primer 5′-TCCATGACAACTTTGGCATTG; and
Gapdh reverse primer 5′-CAGTCTTCTGGGTGGCAGT
GA. The thermocycler settings for cDNA synthesis in-
cluded incubation at 25°C for 5 min, 42°C for 60 min, and
90°C for 5 min. Slc22a12 was not expressed in PND22
mouse liver tissue via qPCR analysis. This finding was
confirmed via the Mouse Genomics Informatics database
(www.informatics.jax.org), which reports no expression of
Slc22a12 in mouse liver. The threshold cycle (CT) was ob-
tained for target gene Myh7b and reference CT was calcu-
lated for glyceraldehydes-3 phosphate dehydrogenase
(Gapdh). Results are reported as ΔCT, which represents
the difference between CT of the target gene versus the
CT of the reference gene. The average ΔCT of the Ctr ex-
posure samples were subtracted from the average ΔCT of
the UG and MG exposure samples to obtain the ΔΔCT
value, and fold change was calculated as 2- ΔΔCT.
CpG island (CGI) annotation
The genomic coordinates for mouse CGIs (mm9) [61]
were downloaded from UCSC Genome Browser. The
genomic regions flanking up to 2 kb (0 – 2 kb from
CGI) that do not overlap with nearby CGIs were defined
as CGI shores. The genomic regions flanking up to 2 kb
from CGI shores (2 - 4 kb from CGI), that do not over-
lap with nearby CGIs and CGI shores are defined as
CGI shelves [34,62].
Additional files
Additional file 1: Figure S1. CpG Islands Are Enriched in the
MethylPlex Library. MethylPlex-Next Generation Sequencing (M-NGS)
reads aligned to mouse chromosome 8 are shown using the UCSC
genome browser with Refseq gene and CpG Island (CGI) density.
MethylPlex reads are enriched in regions containing higher numbers
of genes and CGIs. Figure S2. MethylPlex Reads Alignment on Chromo-
some Y Distinguishes Males and Females. A sex-based analysis of reads
aligned to the chromosome Y was performed for initial standardization
of the analysis pipeline. Methylation differences are revealed between
males and females in raw tag counts with minimal background in
chromosome Y in females. No regions from chromosome Y were identi-
fied to harbor the hypermethylation in females after applying filters for
identifying differential reads using neighboring windows and number of
samples harboring the methylation in a 100 bp window. Figure S3.
Genomic Distribution of Differentially Methylated Windows Between Male
and Female Offspring. Despite limited power, sex differences are identi-
fied, and future studies with sufficient power should address sex-specific
effects of exposures on the methylome. Figure S4. Characterization of
Genome-Wide BPA Exposure Dependent Regions of Altered Methylation
(RAMs). (A) Bar charts representing the genomic distribution of RAMs
(p-value < 0.05) reveal both hyper- and hypomethylation across exposure.
(B) Venn diagram reveals distinct RAMs across exposures. (C) Pie charts
display distribution of RAMs detected in CGIs, CGI shores, and shelves.
In Ctr vs. MG and UG vs. MG comparisons, approximately half of the
Kim et al. BMC Genomics 2014, 15:30 Page 13 of 15
http://www.biomedcentral.com/1471-2164/15/30
changes occur in CGI shore (0-2kb from CGI). Figure S5. Pie Charts of
the Genome-wide Distribution of CGIs, CGI shores, and CGI shelves in
the (A) Mouse Genome and (B) Hypo and Hypermethylated Regions
of Altered Methylation (RAMs). The majority of methylation changes
observed in BPA-exposed mouse liver samples were located in CGI shores.
Additional file 2: Table S1. Sample table. Table S2. Gender-based
differentially methylation regions. Table S3. Candidate regions. Table S4.
Enriched GO terms and pathways in differentially methylated regions.
Table S5. Enriched GO terms and pathways of BPA-interacting genes.
Table S6. ChIP-Enrich analysis results. Table S7. EpiTYPER primers and
PCR conditions.
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